PRRT2 and infection: Even after controlling for reduced fusion, infection was still significantly diminished by treatment with PKC and PDPK1 inhibitors (Additional file 1: Table S5, Fig. 5d), indicating that these kinases influence both fusion as well as post-entry stages of infection.